# US 2010/0144630 A1 · Compositions, methods and uses for inhibition and/or treatment of influenza infection

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2010/0144630 A1
- Document ID: US20100144630A1
- Status: Published application
- Kind: A1
- Application number: 12/589,221
- Filed: 2009-10-20
- Published: 2010-06-10
- Earliest claimed: 1999-03-05
- Inventors: Leland Shapiro
- Web page: https://patentgrep.com/patent/US20100144630A1

## CPC

- A61K 38/57: from animals; from humans {(A61K38/553, A61K38/556 take precedence)}
- A61P 31/12: Antivirals
- A61P 31/14: for RNA viruses
- A61P 31/16: for influenza or rhinoviruses
- A61P 31/18: for HIV
- A61P 31/20: for DNA viruses
- A61P 31/22: for herpes viruses
- A61P 37/04: Immunostimulants
- Y02A 50/30: Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- Y02A: TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE

## Abstract

Embodiments of the present invention illustrate methods and compositions for treating medical disorders. In certain embodiments, compositions and methods relate to reducing or inhibiting onset, transmission or development of a viral disorder.

## Claims

### Claim 1

A method for modulating shedding of a virus in a subject infected with the virus comprising, administering to the subject having a viral infection a therapeutically effective amount of a composition comprising one or more peptides derived from the carboxyterminal 80 amino acids of SEQ ID NO:20 corresponding to amino acid 315 and ending at amino acid 394, wherein the composition modulates shedding of the virus.

### Claim 2 (depends on 1)

The method of claim 1, wherein the virus comprises HIV, AIDS (acquired immunodeficiency syndrome), influenza virus, hepatitis virus, Herpes virus, human papilloma virus, Variola major virus (small pox), Lassa fever virus, avian influenza, AIDS Related Complex, Chickenpox (Varicella), Common cold, Cytomegalovirus, Colorado tick-associated viruses, Dengue, Ebola virus, Hepatitis, Herpes simplex, Herpes zoster, HPV, Infectious mononucleosis-associated virus, PolioRabies, Rubella, SARS, Smallpox (Variola), pneumonia, West Nile, and a combination thereof.

### Claim 3 (depends on 1)

The method of claim 1, wherein the composition comprises one or more peptide comprising FVFLM (SEQUENCE ID NO. 1), FVFAM (SEQUENCE ID NO. 2), FVALM (SEQUENCE ID NO. 3), FVFLA (SEQUENCE ID NO. 4), FLVFI (SEQUENCE ID NO. 5), FLMII (SEQUENCE ID NO. 6), FLFVL (SEQUENCE ID NO. 7), FLFVV (SEQUENCE ID NO. 8), FLFLI (SEQUENCE ID NO. 9), FLFFI (SEQUENCE ID NO. 10), FLMFI (SEQUENCE ID NO. 11), FMLLI (SEQUENCE ID NO. 12), FIIMU (SEQUENCE ID NO. 13), FLFCI (SEQUENCE ID NO. 14), FLFAV (SEQUENCE ID NO. 15), FVYLI (SEQUENCE ID NO. 16), FAFLM (SEQUENCE ID NO. 17), AVFLM (SEQUENCE ID NO. 18), and a mixture thereof.

### Claim 4 (depends on 1)

The method of claim 1, wherein the composition comprises one or more peptide comprising GADLSGVTEE (SEQ ID NO:21); KAVLTIDEKG (SEQ ID NO:22); TEAAGAMFLE (SEQ ID NO:23); RIPVSIPPEV (SEQ ID NO:24); KFNKPFVFLM (SEQ ID NO:25); IEQNTKSPLF (SEQ ID NO:26); MGKVVNPTQK (SEQ ID NO:27); LSGVTEEAPL (SEQ. ID NO. 28); KLSKAVHKAV (SEQ. ID NO. 29); LTIDEKGTEA (SEQ. ID NO. 30); AGAMFLERIP (SEQ. ID NO. 31); VSIPPEVKFN (SEQ. ID NO. 32); KPFVFLMIEQ (SEQ. ID NO. 33); NTKSPLFMGK (SEQ. ID NO. 34); VVNPTQK (SEQ. ID NO. 35); LEAIPMSIPPEVKFNKPFVFLM (SEQ ID NO: 36); LEAIPMSIPPEVKFNKPFVF (SEQ ID NO: 37) or a mixture thereof.

### Claim 5 (depends on 1)

The method of claim 1, wherein the virus is influenza.

### Claim 6 (depends on 6)

The method of claim 6, wherein the composition comprises FVFLM (SEQUENCE ID NO. 1) or analog thereof, FVYLI (SEQUENCE ID NO. 16), LEAIPMSIPPEVKFNKPFVFLM (SEQ ID NO: 36); and LEAIPMSIPPEVKFNKPFVF (SEQ ID NO: 37) or a mixture thereof.

### Claim 7 (depends on 1)

The method of claim 1, wherein the composition further comprises an agent selected from the group consisting of an anti-inflammatory agent, an immunosuppressive agent, an immunomodulatory agent, an anti-viral agent, an anti-pathogenic agent, an anti-bacterial agent, a reverse transcriptase inhibitor, a protease inhibitor, and a combination thereof.

### Claim 8 (depends on 1)

The method of claim 1, wherein the composition is administered orally, systemically, via an implant, intravenously, topically, intrathecally, by inhalation, nasally or a combination thereof.

### Claim 9 (depends on 1)

The method of claim 1, wherein the composition is administered by inhalation, nasally or a combination thereof.

### Claim 10

A method for modulating shedding of a virus in a subject infected with the virus comprising, administering to the subject having a viral infection a therapeutically effective amount of a composition comprising SEQ ID NO:20, wherein the composition modulates shedding of the virus.

### Claim 11

A composition for modulating shedding of a virus in a subject infected with the virus comprising, one or more peptides derived from the carboxyterminal 80 amino acids of SEQ ID NO:20 beginning at amino acid 315 and ending at amino acid 394, the composition modulates shedding of the virus from a cell.

### Claim 12 (depends on 11)

The composition of claim 11, wherein the composition comprises FVFLM (SEQUENCE ID NO. 1), an analog of FVFLM comprising FVYLI (SEQUENCE ID NO. 16), or a mixture thereof.

### Claim 13 (depends on 11)

The composition of claim 11, wherein the composition comprises GADLSGVTEE (SEQ ID NO:21); KAVLTIDEKG (SEQ ID NO:22); TEAAGAMFLE (SEQ ID NO:23); RIPVSIPPEV (SEQ ID NO:24); KFNKPFVFLM (SEQ ID NO:25); IEQNTKSPLF (SEQ ID NO:26); MGKVVNPTQK (SEQ ID NO:27); LSGVTEEAPL (SEQ. ID NO. 28); KLSKAVHKAV (SEQ. ID NO. 29); LTIDEKGTEA (SEQ. ID NO. 30); AGAMFLERIP (SEQ. ID NO. 31); VSIPPEVKFN (SEQ. ID NO. 32); KPFVFLMIEQ (SEQ. ID NO. 33); NTKSPLFMGK (SEQ. ID NO. 34); VVNPTQK (SEQ. ID NO. 35); LEAIPMSIPPEVKFNKPFVFLM (SEQ ID NO: 36); LEAIPMSIPPEVKFNKPFVF (SEQ ID NO: 37) or a mixture thereof.

### Claim 14 (depends on 11)

The composition of claim 11, further comprises at least one of an anti-viral agent and an anti-pathogenic agent.

### Claim 15 (depends on 11)

The composition of claim 11, wherein virus comprises influenza.

### Claim 16 (depends on 15)

The composition of claim 15, wherein influenza virus comprises H1N1.

### Claim 17

A kit for modulating shedding of a virus comprising:
at least one container; and
at least one composition comprising one or more of FVFLM (SEQUENCE ID NO. 1), an analog of FVFLM comprising FVYLI (SEQUENCE ID NO. 16), GADLSGVTEE (SEQ ID NO:21); KAVLTIDEKG (SEQ ID NO:22); TEAAGAMFLE (SEQ ID NO:23); RIPVSIPPEV (SEQ ID NO:24); KFNKPFVFLM (SEQ ID NO:25); IEQNTKSPLF (SEQ ID NO:26); MGKVVNPTQK (SEQ ID NO:27); LSGVTEEAPL (SEQ. ID NO. 28); KLSKAVHKAV (SEQ. ID NO. 29); LTIDEKGTEA (SEQ. ID NO. 30); AGAMFLERIP (SEQ. ID NO. 31); VSIPPEVKFN (SEQ. ID NO. 32); KPFVFLMIEQ (SEQ. ID NO. 33); NTKSPLFMGK (SEQ. ID NO. 34); VVNPTQK (SEQ. ID NO. 35); LEAIPMSIPPEVKFNKPFVFLM (SEQ ID NO: 36); LEAIPMSIPPEVKFNKPFVF (SEQ ID NO: 37) or a mixture thereof.

### Claim 18 (depends on 17)

The kit of claim 17, wherein the composition comprises FVFLM (SEQUENCE ID NO. 1), an analog of FVFLM comprising FVYLI (SEQUENCE ID NO. 16), or a mixture thereof.

### Claim 19 (depends on 17)

The kit of claim 17, further comprising an anti-viral agent.

### Claim 20

A method for modulating influenza infection of cells of a subject comprising, administering to the subject having an influenza infection a therapeutically effective amount of a composition comprising SEQ ID NO:20 or one or more peptides derived from the carboxyterminal 80 amino acids of SEQ ID NO:20 corresponding to amino acid 315 and ending at amino acid 394, modulating hemagluttinin processing of influenza wherein modulating hemagluttinin processing of influenza reduces infectivity of influenza.
